✦ LIBER ✦

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks

✍ Scribed by Paul E Sax; Edwin DeJesus; Anthony Mills; Andrew Zolopa; Calvin Cohen; David Wohl; Joel E Gallant; Hui C Liu; Lijie Zhong; Kitty Yale; Kirsten White; Brian P Kearney; Javier Szwarcberg; Erin Quirk; Andrew K Cheng

Book ID: 117310464
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 383 KB
Volume: 379
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(12)60917-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Co-formulated elvitegravir, cobicistat,

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial

✍ Edwin DeJesus; Jürgen K Rockstroh; Keith Henry; Jean-Michel Molina; Joseph Gathe 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 339 KB

Simplification to coformulated elvitegra

Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week results of a randomised, open-label, phase 3b, non-inferiority trial

✍ Arribas, Jose R; Pialoux, Gilles; Gathe, Joseph; Di Perri, Giovanni; Reynes, Jac 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 260 KB

Switching to coformulated elvitegravir,

Switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of non-nucleoside reverse transcriptase inhibitor with emtricitabine and tenofovir in virologically suppressed adults with HIV (STRATEGY-NNRTI): 48 week results of a randomised, open-label, phase 3b non-inferiority trial

✍ Pozniak, Anton; Markowitz, Martin; Mills, Anthony; Stellbrink, Hans-Juergen; Ant 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 274 KB